RNTX
Financials
- Market Capitalization 65.56 M
- Employee 10
- Founded 2001
- CEO N/A
- Website www.reintx.com
- Headquarter Texas, United States
- FIGI BBG002454KR1
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4132 |  CSBR Champions Oncology, Inc. - Common Stock | 4.93 USD | -1.79% | -2.76% | -6.10% | -25.98% | 68.50 M USD | ||
| 4141 |  IBIO iBio, Inc. - Common Stock | 1.36 USD | -2.86% | -5.56% | 0.00% | -40.87% | 67.56 M USD | ||
| 4158 |  PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.22 USD | -1.61% | -8.27% | +15.09% | -12.86% | 65.22 M USD | ||
| 4160 |  HYFT MindWalk Holdings Corp. - Common Stock | 1.39 USD | -2.11% | 0.00% | +6.92% | -31.19% | 64.93 M USD |
Frequently asked questions about Rein Therapeutics, Inc. Common Stock
What is the Rein Therapeutics, Inc. Common Stock stock price today?
The current price of Rein Therapeutics, Inc. Common Stock (RNTX) is 0.76. Over the past 24 hours, the stock has changed by -2.56%. Follow the RNTX chart for real-time price dynamics.
What is the stock ticker of Rein Therapeutics, Inc. Common Stock?
Rein Therapeutics, Inc. Common Stock trades under the ticker RNTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Rein Therapeutics, Inc. Common Stock stock going up?
RNTX has changed by -7.32% over the last week, 0.00% over the last month, and -30.93% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Rein Therapeutics, Inc. Common Stock?
Rein Therapeutics, Inc. Common Stock currently has a market capitalization of 65.56 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Rein Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Rein Therapeutics, Inc. Common Stock reported earnings of -0.1 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Rein Therapeutics, Inc. Common Stock revenue for the last quarter?
Rein Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Rein Therapeutics, Inc. Common Stock net income for the last quarter?
Rein Therapeutics, Inc. Common Stock reported net income of -6.38 M for the last quarter. The previous quarter showed -5.84 M, which means net income changed by -9.20%.
Is Rein Therapeutics, Inc. Common Stock a good dividend stock?
Rein Therapeutics, Inc. Common Stock currently has a dividend yield of 0%. Previously, the dividend yield was 0%, compared with 0% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.
How many employees does Rein Therapeutics, Inc. Common Stock have?
As of the latest available data, Rein Therapeutics, Inc. Common Stock has 10 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Rein Therapeutics, Inc. Common Stock stock?
You can buy Rein Therapeutics, Inc. Common Stock (RNTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Rein Therapeutics, Inc. Common Stock stock?
Investing in Rein Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RNTX chart and related analysis on metatrader.com as part of your research.